Adam M. Brufsky, MD: So, the last part of our discussion really is, I think, addressing one of the big challenges that we have with breast cancer. I think we’ve done a really good job. We could do better, but we’ve done a really good job so far with ER-positive breast cancer. I think we’ve done a very good job with HER2-positive breast cancer. But really, triple-negative breast cancer now is a topic that is, I think, on everybody’s minds. First of all, what is it? I think we’re not 100% sure what triple-negative breast cancer really is. Is it a diagnosis of exclusion? Does it have real characteristics? But, more importantly, what do we do when someone comes in to our clinics with that diagnosis of triple-negative breast cancer?

Click to Read More